Spinal epidural abscess (SEA) is a rare but potentially devastating condition. We noticed an increase in the number of cases of SEA, with the majority in hemodialysis (HD) patients. This prompted a retrospective chart review of all cases of SEA admitted from 2000 to 2005 and a literature search of similar cases. We identified 19 SEA cases treated at Long Island College Hospital during this 6-year period, of which six were on HD: four were dialyzed via catheter, one via arteriovenous fistula, and in one the method of dialysis was not documented. Four patients had bacteremia with Staphylococcus aureus. Four patients presented with paresis or paralysis; only one improved. The mortality rate was 33% (2/6). We found 30 other cases of SEA in patients on HD from the literature. These 36 HD cases were compared with 85 SEA cases that were not on HD (13 from our study and 72 described in two large case series). The mortality rate was noted to be much higher in HD patients (23% [6/26] versus 7% [6/85]). Neurologic deficit at presentation was noted in 47% (17/36) of HD patients versus 69% (59/85) of non-HD patients, but neurologic improvement was higher in non-HD patients (71% [42/59] versus 29% [5/17]). This is the largest literature review of SEA in patients on HD. When compared with non-HD patients, HD patients had a higher mortality rate and were less likely to improve neurologically.
Introduction
A spinal epidural abscess (SEA) is a rare but potentially devastating condition. There have been many descriptions of this disease , but only a few have concerned hemodialysis (HD) patients. Long Island College Hospital is a 516-bed urban teaching community hospital with a large dialysis center composed of 28 outpatient beds and six inpatient beds. We noticed an increase in the number of cases of SEA in 2005, with the majority in HD patients. This prompted a review of all cases of SEA admitted from January 2000 to December 2005 and a literature search of similar cases.
Materials and Methods
This study is a retrospective chart review of all patients with SEA who were treated at Long Island College Hospital over a six-year period. We identified all SEA cases by using electronic billing records. Inclusion criteria were all cases of SEA proven radiographically or microbiologically between 2000 and 2005. We reviewed paper medical records and electronic laboratory and radiographic reports for patient demographics, predisposing factors, clinical presentations, causative organisms, diagnostic and treatment modalities, and outcomes. A literature search for all reported cases of SEA in HD patients was done, and comparisons were made to constitute this literature review.
Results
We identified 19 SEA cases treated at Long Island College Hospital during this six-year period ( Figure 1 ). The mean age of these 19 patients was 57 years with 10 men and nine women. Thirteen (68%) patients were African Americans and six were Caucasians. Comorbid conditions included diabetes mellitus (58% [11/19] ); chronic kidney disease (42% [8/19] ), of which six were on HD; malignancy (11% [2/19] ); intravenous drug use (26% [5/19] ), of which three were active and two were remote users; and previous spinal instrumentation or underlying spinal disease or abnormalities (32% [6/19] ).
About half of the patients presented with fever (53% [10/19] ), 74% (14/19) had back pain, and 58% (11/19) developed a new neurologic deficit. The full clinical triad of fever, back pain, and neurologic deficit was observed in four (21%) patients. Leukocytosis was present in 42% (8/19) of patients, and the erythrocyte sedimentation rate was elevated in nine (75%) of 12 patients in whom it was measured.
Magnetic resonance imaging (MRI) was used as the primary imaging tool for diagnosis in all 19 patients. The anatomical sites of involvement were both in the cervical and lumbosacral regions in 42% (8/19) and in the thoracic region in 37% (7/19 (Table 1) . Clinical manifestations of SEA include back pain, radicular pain, motor weakness, sensory changes, bladder or bowel dysfunction, and paralysis. New neurologic deficits with the exclusion of back pain were identified in 11 (58%) of our patients; one patient had baseline paraplegia. Neurologic improvement defined by improvement from paralysis or paresis to any lower entity was observed in two (18%) of 11 patients at the end of treatment. One of these two patients had surgery, and the other was treated medically. The rest of the patients showed no improvement or worsening of their neurologic symptoms from the time of presentation.
Of 19 patients, 10 (53%) underwent surgical decompression and two (11%) were treated with percutaneous drainage. The types of surgery performed were decompression and laminectomy in eight patients and diskectomy in two patients. Of the remaining seven patients who received only medical treatment, four patients did not have neurologic deficits, surgery was deferred in one who showed signs of either radiographic or clinical improvement, and one refused surgery. Surgery was contraindicated in one patient because of concerns of destabilizing the spine. Three patients who did not have neurologic deficit underwent surgical intervention. We were able to follow the patients until the end of the same hospital stay or until they died during the same admission, whichever came first, and found that all-cause mortality was 21% (4/19). Three (25%) of 12 surgically managed patients and one (14%) of seven medically managed patients died.
Eighteen (95%) patients received empiric antibiotics at the time of presentation before the drainage cultures were obtained. One patient was initially diagnosed with metastatic prostate cancer and did not receive antibiotics until surgery was done. Treatment with definitive antibiotics after culture results included vancomycin in 11 (58%) of 19 patients, of which six patients received combined therapy with rifampin and/or gentamicin; nafcillin in five (26%); ceftriaxone in two (11%); and ampicillin-sulbactam in one (5%). Some (32% [6/19] ) patients also received a combination of vancomycin with one other gram-negative agent before culture results or if cultures were negative. The duration of treatment with parenteral antibiotics was 6 to 8 weeks in most patients, except in those who died 2 to 5 weeks after onset.
In our study, six of 19 cases were on HD, with two in 2000 and four in 2005. The mean age of HD patients with SEA was 60 years, with an equal number of men and women; all were African Americans. The average duration of HD before the current admission was 38.2 months. Of these six patients, four were dialyzed via catheter and one via arteriovenous (AV) fistula; in one, the method of dialysis was not documented. A recent infection, bacteremia, or other focal infection within three months of the current admission was noted in four patients. Four cases presented with fever and back pain, but only three had leukocytosis on presentation. Three patients developed SEA in the cervical spinal region, three in the thoracic, and two in the lumbar region, with extensive spinal involvement of all three regions in one patient.
Four HD patients had bacteremia, with two each of MSSA and MRSA, and two patients had negative blood cultures. Three patients underwent surgical decompression and one had percutaneous drainage. Only one of four abscess cultures grew MSSA, possibly because the time from the initiation of antibiotics to surgery averaged 7.8 days. Four patients presented with paresis or paralysis and only one improved. Average duration of treatment with appropriate antibiotics was 6.5 weeks, and the all-cause mortality rate was 33% (2/6) among HD patients.
Discussion
SEA refers to a localized collection of pus between the dura mater and the overlying skull or vertebral column. The incidence of this disease-2 decades ago diagnosed in approximately one of 20,000 hospital admissions-has doubled in the past two decades (1). SEA occurs hematogenously in about half of the cases or by extension from vertebral osteomyelitis in about one-third of cases. The source is not identified in 20% to 40% of cases.
Predisposing risk factors include diabetes mellitus (about 50% of cases), alcoholism, immunocompromised states such as HIV or malignancy, spinal abnormality or intervention, and sepsis of any source. Bacteremia is also an important predisposing factor because the incidence of SEA is increased in patients who use injection drugs and in those who have intravenous catheters or infective endocarditis (2, 3) .
MRI with gadolinium enhancement is the most sensitive radiologic test. Computed tomography (CT) myelography is also very sensitive but should be performed only if an MRI is unavailable or contraindicated because the MRI is less invasive and superior to CT in the identification and delineation of the collections. Previous reports (3,4) revealed that the thoracic or lumbar spines were most com- monly affected, but we found similar frequency among the cervical, thoracic, and lumbar spinal regions.
The occurrence of SEA in HD patients has received little attention. Darouiche (1) found 24 reported series of SEA but only a handful of those (5-10) included HD patients. From our literature search, we found 30 other cases of SEA in patients on HD (5-7) ( Table 2 ). With our study, 36 HD cases with SEA were compared with 85 SEA cases that were not on HD (13 from our study and 72 described in two large case series with the best parameters for comparison) (8, 11) . The mortality rate among HD patients was noted to be 23% (6/26) and was not reported in 10 patients (5). This is much higher than non-HD patients (7% [6/85] Comparing the two groups, the mean age was 61 years in HD and 53 years in non-HD patients. sixty-nine percent had underlying diabetes mellitus in the HD group as opposed to 36% in the non-HD group. The incidence of fever (56% in HD and 62% in non-HD) and back pain (85% and 83%, respectively) were about the same, but leukocytosis was present less often in HD patients (46% versus 69%). The lumbosacral spine was the most commonly involved area in both groups (44% [16/36] and 53% [45/85], respectively); more than one spinal region was involved in 11% (4/36) of the HD group compared with 15% (13/85) of the non-HD group.
Spinal cultures were obtained in 24 (67%) of the HD group and 81 (95%) of the non-HD group, with positive results in 15 (63%) of 24 HD patients and 78 (96%) of 81 non-HD patients. S. aureus was the predominant organism in both groups: 46% (11/24) of HD patients and 56% (45/ 81) of non-HD patients; however, some of the case series The management of SEA includes a combined medical and surgical approach. Empiric parenteral antimicrobial therapy should be started as soon as SEA is clinically suspected and should include a first-line antistaphylococcal agent for MRSA (e.g. vancomycin) pending culture result and an antibiotic for aerobic gram-negative bacilli (usually third-or-fourth generation cephalosporin with anti-pseudomonal activity such as ceftazidime or cefepime). Once the abscess culture results are available, antimicrobial therapy should be modified on the basis of organisms and susceptibility; the duration of treatment is usually 6 to 8 weeks.
The majority of retrospective studies (1, 4, 9, (12) (13) (14) (15) concluded that surgical drainage with systemic antimicrobial therapy is the best treatment. Although nobody doubts that emergent surgical decompression is indicated for patients with neurologic dysfunction secondary to SEA, there have been no prospective randomized controlled trials to compare the outcomes of medical treatment alone versus combined medical and surgical treatment. One literature review (16) reported that among 38 patients treated with antimicrobial therapy alone, only two (5%) died and one worsened, and the rest remained the same or improved. In our study, of 12 patients who underwent surgery, three (25%) patients died and only one showed neurologic improvement, whereas one (14%) death and one improvement was observed in seven patients who were treated with antimicrobial therapy alone. Nevertheless, all patients with SEA should be assessed for surgical intervention from the time of onset given that the rate of progression of neurologic impairment is unpredictable and can be rapid.
Regarding HD patients, National Kidney FoundationKidney Disease Outcomes Quality Initiative clinical practice guidelines for vascular access (25) have recommended that AV fistulae should be the preferred mode of permanent vascular access, and AV graft is acceptable only if fistula placement is not possible given that primary AV fistulae have the lowest rates of infections, thrombosis, and mortality (26 -28) . Cuffed tunneled central venous catheters should be discouraged as permanent vascular access. However, it is recommended that the fistula access must be created 6 months in advance of the anticipated need for dialysis. Unfortunately, because of late referrals or deferred by patients, the establishment of permanent access is delayed often, and synthetic grafts or temporary indwelling catheters have to be used while the fistula matures.
Vascular access-related infection remains a major cause of morbidity and mortality among HD patients. Those receiving HD via indwelling catheters have the highest incidence of infection, bacteremia, and metastatic complications, including endocarditis, osteomyelitis, septic arthritis, septic pulmonary emboli, and SEA. Although the incidence of bacteremia is relatively low among patients using AV fistulae, there have been reports that buttonhole cannulation of native AV fistulae is associated with increased risk of infection as well (29 -31) . One of the recent reports described the association of buttonhole cannulation and S. aureus bacteremia complicated by epidural abscess (29) .
Infection is the second leading cause of death after cardiovascular cause among HD patients, and the source of infection is most often related to vascular access (mainly catheter) (26) . In our review, 61% (22/36) of HD patients were receiving dialysis via catheters at the time of development of SEA. Physicians should have a high index of clinical suspicions for diagnosis of spinal infection in dialysis patients with back pain or other neurologic symptoms given that early diagnosis and treatment are crucial.
Conclusions
This is the largest literature review of SEA in patients on HD. When compared with non-HD patients, HD patients had a higher mortality and were less likely to improve neurologically. The increase in the number of cases in our institute in 2005 may be related to increased use of dialysis catheters while awaiting maturation of AV fistulae, which is the preferred mode of access for HD.
